Alverix, Inc.: Series A $7.7M

Posted in I - Series A, Q - 1Q08, R - NORTH EAST, X - Diagnostic

Alverix (Wayne, Pa) developer of point-of-care diagnostics devices closed a $7.7M Series A financing. Participants include New Venture Partners and Safeguard Scientifics.

PEAK Surgical, Inc.: Series C $21M

Posted in I - Series C, Q - 1Q08, R - WEST, X - Device (Electrosurgery)

PEAK Surgical (Palo Alto, CA) an early-stage medical device company focused on pulsed plasma electrosurgery for cutting, coagulation and tissue welding closed a $21M Series C financing. Participants include Signet Healthcare Partners, Lehman Brothers and Venrock Associates.

Traversa Therapeutics, Inc.: Series A $2M

Posted in I - Series A, Q - 1Q08, R - WEST, X - RNAi

Traversa Therapeutics (La Jolla, CA) a discovery and development stage focused on RNAi delivery closed a $2M Series A financing. Participants include San Diego Tech Coast Angels, Mesa Verde Venture Partners and Morningside Group.

Sonexa Therapeutics, Inc.: Series A $30M

Posted in I - Series A, Q - 1Q08, R - WEST, X - Alzheimer's

Sonexa Therapeutics (San Diego, CA) a development stage company focused Alzheimer’s closed a $30M Series A financing. Participants include Domain Associates, Scale Venture Partners, Alta Partners, AgeChem Venture Fund and MC Life Science Ventures.

BioVascular, Inc.: Series C $10.8M

Posted in I - Series C, Q - 1Q08, R - WEST, X - Cardiology

BioVascular (San Diego, CA) a development stage biotechnology company focused on novel cardiovascular therapeutics closed a $10.8M Series C financing. Participants include BB Biotech Ventures and Domain Associates.

NGM Biopharmaceuticals, Inc.: Series A $25.5M

Posted in I - Series A, Q - 1Q08, R - WEST, X - Metabolism

NGM Biopharmaceuticals (Hillsborough, CA) an early-stage drug development company focused on metabolic diseases closed a $25.5M Series A financing. Participants include Column Group, Prospect Venture Partners and Rho Ventures.

ViewRay, Inc.: Series B $25M

Posted in I - Series B, Q - 1Q08, R - SOUTH EAST, X - Device (Imaging), X - Device (Radiotherapy)

ViewRay (Gainesville, FL) maker of a MRI-guided radio-therapy delivery device, closed a $25M Series B financing. Participants include OrbiMed, Fidelity Biosciences, Aisling Capital, Kearny and Venture Partners.

Knopp Neurosciences, Inc.: Series B $10M

Posted in I - Series B, Q - 1Q08, R - NORTH EAST, X - ALS, X - Neurology

Knopp Neurosciences (Pittsburgh, PA) a drug discovery and development company focused on neurological disorders with a lead compound for amyotrophic lateral sclerosis closed a $10M Series B financing. Participants include Saturn Partners, Kramer Capital Partners and LaunchCyte.

Mauna Kea Technologies: Series B $30M

Posted in I - Series B, Q - 1Q08, R - INTERNATIONAL, X - Device (Imaging)

Mauna Kea Technologies (France) a MIS in-vivo imaging platform has closed a $30M Series B financing. Participants include Psilos Group, Seventure and Creadev.

Endotis Pharma: Series B $36.59M

Posted in I - Series B, Q - 1Q08, R - INTERNATIONAL, X - Oncology, X - Thrombosis

Endotis Pharma (France) a specialty discovery and development company developing small glycol drugs for thrombosis and oncology closed a $36.59M Series B financing. Participants include Wellcome Trust, Endeavour vision, NIF SMBC Ventures and Sofinnova Partners.

« Previous Entries Next Entries »

to top of page...